dipyridamole has been researched along with Hepatitis B Virus Infection in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, T | 1 |
| Horiuchi, T | 1 |
| Kamitsuji, H | 1 |
| Murakami, T | 1 |
| Tamai, H | 1 |
| De Vita, C | 1 |
2 other studies available for dipyridamole and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Horizontal transmission of hepatitis B from a father to two brothers.
Topics: Adult; Carrier State; Child, Preschool; Dipyridamole; Disease Transmission, Infectious; Drug Therapy | 2003 |
[Problems of the operated patient and suggestions for their treatment].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Anxiety Disorders; Arrhythmias, Cardiac; As | 1982 |